Dual JAK/SYK inhibition in refractory NHL with cerdulatinib

Diverse T lymphocyte population fights leukaemia more effectively

Delayed exposure to common infections causes acute childhood leukaemia

Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL

Improving outcomes for oestrogen receptor positive breast cancer

European guidelines for breast cancer treatment

The European Alliance for Personalised Medicine

Europa Uomo - improving prostate cancer patients quality of life across Europe

Personalised medicine for rare cancers

Working With Cancer: helping people affected by cancer return to work

Gastrectomy and oral drug prescription

Improving care for cancer patients